JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.56B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.02B |
| 3 |
Northrop Grumman
NOC
|
+$505M |
| 4 |
Truist Financial
TFC
|
+$502M |
| 5 |
Analog Devices
ADI
|
+$492M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.78B |
| 2 |
Tesla
TSLA
|
+$855M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$828M |
| 4 |
Verizon
VZ
|
+$792M |
| 5 |
Microsoft
MSFT
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.16% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Healthcare | 9.79% |
| 4 | Financials | 9.43% |
| 5 | Industrials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
MannKind Corp
MNKD
$1.2B
| $157K | ﹤0.01% |
82,121
+10,043
| +14% | +$17.4K |
|
|
IVAC
4302
DELISTED
Intevac Inc
IVAC
| $157K | ﹤0.01% |
27,589
+6,055
| +28% | +$34.9K |
|
4303
Stoke Therapeutics
STOK
$2.11B
| $156K | ﹤0.01% |
4,554
-137
| -3% | -$3.91K |
|
|
EVA
4304
DELISTED
Enviva Inc.
EVA
| $156K | ﹤0.01% |
4,000
+2,601
| +186% | +$102K |
|
|
AERI
4305
DELISTED
Aerie Pharmaceuticals
AERI
| $156K | ﹤0.01% |
13,676
+1,248
| +10% | +$15.2K |
|
4306
CEL-SCI Corp
CVM
$27.1M
| $155K | ﹤0.01% |
419
+48
| +13% | +$18.9K |
|
4307
Kiniksa Pharmaceuticals
KNSA
$6.13B
| $155K | ﹤0.01% |
9,965
+3,550
| +55% | +$66.6K |
|
4308
CALL
Lockheed Martin
LMT
$134B
| $155K | ﹤0.01% |
+400
| New | +$153K |
|
|
KIN
4309
DELISTED
Kindred Biosciences, Inc.
KIN
| $155K | ﹤0.01% |
35,221
-10,056
| -22% | -$42K |
|
4310
Annexon
ANNX
$893M
| $154K | ﹤0.01% |
+5,496
| New | +$129K |
|
4311
Nature's Sunshine
NATR
$355M
| $154K | ﹤0.01% |
13,467
+2,887
| +27% | +$30.9K |
|
4312
Riverview Bancorp
RVSB
$109M
| $154K | ﹤0.01% |
37,572
-817
| -2% | -$3.66K |
|
4313
Star Bulk Carriers
SBLK
$3.16B
| $154K | ﹤0.01% |
22,733
+20,624
| +978% | +$139K |
|
|
SP
4314
DELISTED
SP Plus Corporation
SP
| $154K | ﹤0.01% |
8,580
+799
| +10% | +$14.7K |
|
4315
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
| $153K | ﹤0.01% |
3,750
-500
| -12% | -$20.9K |
|
4316
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$905M
| $153K | ﹤0.01% |
+5,850
| New | +$155K |
|
4317
RGC Resources
RGCO
$223M
| $153K | ﹤0.01% |
6,450
+14
| +0.2% | +$329 |
|
|
ALR
4318
DELISTED
AlerisLife Inc
ALR
| $153K | ﹤0.01% |
29,923
+23,426
| +361% | +$112K |
|
4319
Crinetics Pharmaceuticals
CRNX
$8.91B
| $152K | ﹤0.01% |
10,087
+952
| +10% | +$14.6K |
|
4320
First Capital
FCAP
$217M
| $152K | ﹤0.01% |
2,683
+1,035
| +63% | +$62.5K |
|
4321
Hyster-Yale Materials Handling
HY
$709M
| $152K | ﹤0.01% |
4,048
-4,037
| -50% | -$159K |
|
4322
PUT
Vanguard S&P 500 ETF
VOO
$1.01T
| $152K | ﹤0.01% |
900
-800
| -47% | -$244K |
|
4323
Franklin Covey
FC
$242M
| $151K | ﹤0.01% |
8,421
-20,887
| -71% | -$401K |
|
4324
RPC Inc
RES
$1.3B
| $151K | ﹤0.01% |
56,004
-427,939
| -88% | -$1.33M |
|
4325
Schwab US Large- Cap ETF
SCHX
$74.2B
| $151K | ﹤0.01% |
11,352
+6,900
| +155% | +$91.7K |
|
Similar funds
JP Morgan Chase's Q3 2020 Portfolio in Review
As of Q3 2020, JP Morgan Chase held 6,064 positions worth $595B, up 15% from $518B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $31B of net new capital in Q3 2020, opening 477 new positions and adding to 2,495 existing holdings. Its largest new stake was Snowflake: 740,935 shares worth $192M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Alibaba, an estimated $1.78B trimmed.
- JP Morgan Chase's largest Q3 2020 buy was Snowflake: 740,935 shares worth $192M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q3 2020 reduction was Alibaba, cutting an estimated $1.78B.
- JP Morgan Chase fully exited IBERIABANK Corp in Q3 2020, selling an estimated $89.7M.
- JP Morgan Chase's ten largest holdings make up 18% of its $595B portfolio in Q3 2020.
- JP Morgan Chase opened 477 new positions and closed 368 in Q3 2020.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $595B.
Based on JP Morgan Chase's 13F filing for Q3 2020, filed 12 Nov 2020.